Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Revenue

Vanda Pharmaceuticals had revenue of $47.65M in the quarter ending September 30, 2024, with 22.76% growth. This brings the company's revenue in the last twelve months to $190.86M, down -9.91% year-over-year. In the year 2023, Vanda Pharmaceuticals had annual revenue of $192.64M, down -24.27%.

• Revenue (ttm): $190.86M
• Revenue Growth: -9.91%
• P/S Ratio: 1.33
• Revenue / Employee: $940,187
• Employees: 203
• Market Cap: 255.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	192.64M	-61.74M	-24.27%
Dec 31, 2022	254.38M	-14.30M	-5.32%
Dec 31, 2021	268.68M	20.51M	8.27%
Dec 31, 2020	248.17M	20.98M	9.23%
Dec 31, 2019	227.19M	34.07M	17.64%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.